Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Healwell Ai Inc. Class A (AIDX.TO)

Healwell Ai Inc. Class A (AIDX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 280,782
  • Shares Outstanding, K 167,132
  • Annual Sales, $ 7,317 K
  • Annual Income, $ -31,597 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -1.07
  • Price/Sales 11.16
  • Price/Cash Flow N/A
  • Price/Book 4.97
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.25
  • Most Recent Earnings $0.02 on 08/12/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Care

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.09 +46.79%
on 10/28/24
2.00 -20.00%
on 11/12/24
+0.20 (+14.29%)
since 10/15/24
3-Month
1.09 +46.79%
on 10/28/24
2.15 -25.58%
on 08/26/24
-0.37 (-18.78%)
since 08/15/24
52-Week
0.65 +146.15%
on 01/31/24
3.26 -50.92%
on 06/11/24
+0.75 (+88.24%)
since 11/15/23

Most Recent Stories

More News
Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030

/CNW/ -- Recently the World Economic Forum released a report that highlights AI's potential to relieve pressure on healthcare systems worldwide, with Mayo...

MSFT : 415.00 (-2.79%)
AIDX.TO : 1.60 (-4.76%)
HWAIF : 1.1480 (-3.37%)
NVDA : 141.98 (-3.26%)
AVAI : 0.5100 (-5.56%)
WELL.TO : 4.86 (-3.19%)
RMD.AX : 36.040 (-1.69%)
RMD : 234.74 (+1.43%)
WHTCF : 3.4800 (-3.28%)
CLOV : 3.04 (-1.30%)
HEALWELL Reports Record Revenue and Increased Customer Activity from Pharmaceutical Partners in Q3-2024

HEALWELL achieved record quarterly revenue from continuing operations of $13.7 million in Q3-2024, 738% higher than the $1.6 million generated in Q3-2023 and 153% higher than the $5.4 million generated...

HWAIF : 1.1480 (-3.37%)
AIDX.TO : 1.60 (-4.76%)
HEALWELL's Pentavere Receives Prestigious Prix Galien USA 2024 Award for Best Digital Health Startup for Its Contributions in AI for Life Sciences Industry

The Prix Galien Award is among the global health innovation industry's most renowned honors, recognizing outstanding biomedical, medical, and technology achievements that improve the human condition and...

HWAIF : 1.1480 (-3.37%)
AIDX.TO : 1.60 (-4.76%)
HEALWELL Provides Corporate Update on Accelerating Commercialization and Expansion of Pharmaceutical Partnerships by Leveraging Its Best-in-Class Patient Identification Capabilities

HEALWELL's AI and data science subsidiaries have executed 5 new Master Services Agreements ("MSA") with new pharmaceutical partners in Q3-2024; bringing the total number of MSAs with life sciences partners...

HWAIF : 1.1480 (-3.37%)
AIDX.TO : 1.60 (-4.76%)
HEALWELL AI to Announce Third Quarter 2024 Financial Results on November 12, 2024

HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, November 12, 2024, at 1:00 pm EST (10:00 am PST).Toronto, Ontario--(Newsfile Corp. - November 4, 2024) - HEALWELL AI Inc. (TSX:...

HWAIF : 1.1480 (-3.37%)
AIDX.TO : 1.60 (-4.76%)
WELL Health and HEALWELL AI Expand Strategic Alliance Agreement to Develop an AI-Enhanced Clinical Trials Program to Accelerate Innovation and Improve Patient Outcomes

WELL Health and HEALWELL AI announce the expansion of their multi-year agreement that allows WELL and HEALWELL to launch and manage clinical trial sites at...

AIDX.TO : 1.60 (-4.76%)
HWAIF : 1.1480 (-3.37%)
WELL.TO : 4.86 (-3.19%)
WHTCF : 3.4800 (-3.28%)
WELL Health and HEALWELL AI Expand Strategic Alliance Agreement to Develop an AI-Enhanced Clinical Trials Program to Accelerate Innovation and Improve Patient Outcomes

WELL Health and HEALWELL AI announce the expansion of their multi-year agreement that allows WELL and HEALWELL to launch and manage clinical trial sites at WELL Health clinic locations across Canada. Leveraging...

HWAIF : 1.1480 (-3.37%)
AIDX.TO : 1.60 (-4.76%)
HEALWELL AI Announces Strategic Investment and Commercialization Agreement with Abstractive Health to Advance Generative AI-Powered Clinical Documentation Solutions

HEALWELL AI completes a strategic investment in NY-based Abstractive Health, alongside lead investor Rho Capital Partners, to support the development of AI-driven clinical documentation technology.Concurrent...

HWAIF : 1.1480 (-3.37%)
AIDX.TO : 1.60 (-4.76%)
Stocks in play: HEALWELL AI Inc.

Announced that Dr. Alexander Dobranowski, CEO of HEALWELL, will be participating at the 17th Annual ...

AIDX.TO : 1.60 (-4.76%)
HEALWELL AI to Present at the LD Micro Main Event XVII

Participating in-person at the LD Micro Main Event XVII from October 28-30th at the Luxe Sunset Boulevard Hotel in Los AngelesToronto, Ontario--(Newsfile Corp. - October 18, 2024) - HEALWELL AI Inc. (TSX:...

HWAIF : 1.1480 (-3.37%)
AIDX.TO : 1.60 (-4.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Healwell AI Inc is a healthcare technology company focused on AI and data science for preventative care. The company operates primary care networks and pioneering how actionable insights from data can be paired with targeted therapeutics to start treating disease before it's too late. Its technologies...

See More

Key Turning Points

3rd Resistance Point 1.81
2nd Resistance Point 1.74
1st Resistance Point 1.67
Last Price 1.60
1st Support Level 1.53
2nd Support Level 1.46
3rd Support Level 1.39

See More

52-Week High 3.26
Fibonacci 61.8% 2.26
Fibonacci 50% 1.95
Fibonacci 38.2% 1.65
Last Price 1.60
52-Week Low 0.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar